Our analysis using TIMER2.0 revealed a significant reduction in GLI1 expression in tumor tissues compared to their matched normal controls in several cancer types, including BLCA, BRCA, KIRP, THCA, and UCEC. Here, GLI1 is linked to neoplasm.